How Stratum Nutrition Turned Eggshell Waste Into Low-Dose, Fast-Acting Collagen

What If Collagen Did Not Have to Take Months to Work?

Most people have been trained to be patient with joint supplements.

They buy a product, take it every day, and wait. Sometimes for weeks. Sometimes for months. The expectation has become so familiar that slow results almost feel normal, especially in a category long shaped by ingredients like glucosamine and chondroitin.

But Stratum Nutrition is challenging that timeline with something most consumers would never expect to find in a joint and skin health product...eggshell membrane!

What began as a practical problem in an egg business, with mountains of eggshells and no clear use for them, became the foundation for one of Stratum’s most researched ingredients: NEM, a branded natural eggshell membrane ingredient designed to support connective tissue, mobility, skin, and healthy aging.

The most compelling part is not only that NEM works at an ultra-low dose of about 500 mg for joint health and 400 mg for skin health. It is that Arun Nair, Chief Commercial Officer at Stratum Nutrition, pointed to one proof point that immediately changes the conversation.

“We even have a one-day pain claim approved by Health Canada for exercise-induced pain,” Arun explained.

For an industry where many joint-health products are associated with long timelines, that matters.

NEM works differently because it is partially hydrolyzed through an enzymatic process, which releases peptides connected to its faster anti-inflammatory effect, while its native collagen component supports longer-term benefits through a mechanism called oral tolerance. Arun described it simply: “So it has got a bifunctional, or it attacks the issue in two different ways.”

That combination is what makes Stratum’s story worth paying attention to.

With 1.75 billion doses sold, mostly in North America, and clinical research that includes double-blind placebo-controlled studies, independent laboratories, and studies across regions including North America, Korea, Turkey, Italy, and Germany, Stratum is not just making an ingredient claim. It is showing how an overlooked byproduct can become a science-backed tool for brands building the next generation of joint, skin, and mobility support.

The Eggshell Waste Problem That Became Stratum’s Breakthrough

In 1993, Hollis Osborne, founder of MOARK egg production and grandfather of Stratum Nutrition’s current CEO, Micah Osborne, recognized a problem that most people in the food industry simply accepted as unavoidable. Egg-breaking facilities were generating enormous amounts of eggshell waste, contributing to an estimated 600,000 tons of waste each year.

For most companies, that waste would have remained a disposal issue.

For the Osborne family, it became a question.

What if something being thrown away still had value?

That question eventually led to research into eggshell components, particularly the thin membrane inside the shell. What appeared insignificant at first turned out to contain a structure with meaningful relevance to connective tissue health. Through investigation, Hollis discovered that eggshell membrane shared similarities with the synovial membrane, the tissue associated with joint function and mobility.

That finding changed the direction of the company.

What started as a waste problem inside a family egg business became the foundation for a new category of wellness ingredients. In 2003, the company that would later become Stratum Nutrition was founded, originally known as Egg Shell Membrane Technologies, with a focus on developing eggshell-derived ingredients for bone and joint health.

The early work required patience.

There was no established playbook for turning eggshell membrane into a branded, clinically studied wellness ingredient. The company had to design experiments, build clinical studies, refine processing methods, and determine whether the ingredient could deliver meaningful benefits in humans.

That process eventually led to NEM, Stratum’s flagship natural eggshell membrane ingredient.

What made NEM compelling was not simply that it came from eggshell membrane. It was that the ingredient appeared to support connective tissue in a way that was both low-dose and fast-acting, two qualities that immediately separated it from more familiar joint-health ingredients.

Over time, Stratum expanded beyond eggshell products, adding complementary ingredients such as curcumin, prebiotics, probiotics, and botanical ingredients like Sage Extra. But the company’s foundation remained the same: identify ingredients with a clear biological purpose, support them with research, and help supplement brands build products around evidence rather than trend cycles.

That foundation is also what explains Stratum’s momentum today.

As consumers have moved away from general wellness products and toward condition-specific supplements backed by science, Stratum’s ingredient portfolio has become increasingly relevant. The company’s growth over the last five to six years reflects that shift, especially as brands look for ingredients that can support mobility, skin health, cognition, inflammation pathways, and healthy aging with clearer claims and stronger research.

Today, Stratum is also moving beyond its North American roots, expanding into Europe and Asia Pacific with new offices and regional teams. That expansion reflects a larger ambition, but it also traces back to the same origin point.

A pile of eggshells. A question no one else was asking.

And a discovery that turned waste into one of the company’s most important wellness innovations.

Why They Still Had to Earn the Market’s Trust Slowly

In many ways, Stratum Nutrition’s biggest challenge was not discovering the value of eggshell membrane. It was helping the industry understand why it deserved to be taken seriously in a category that already had familiar players.

For years, the bone and joint health space was shaped by ingredients like glucosamine and chondroitin. Consumers knew them. Brands understood how to formulate with them. Practitioners were familiar with the timeline, even if that timeline often required patience. In many cases, people expected to wait close to 90 days before noticing meaningful changes.

That created an uphill climb for NEM.

Stratum was not only introducing another joint-health ingredient. It was introducing a different expectation.

A low-dose ingredient that could support joint comfort and mobility faster than many of the category’s established options had to overcome a natural skepticism. When a product category has trained people to wait months, a claim around faster support does not simply create excitement. It raises questions.

That is why the company had to lean heavily on research.

The value of NEM could not rest on a compelling origin story alone. It needed clinical studies, regulatory review, independent validation, and enough real-world use to prove that the ingredient could hold up beyond early interest.

This is where Stratum’s science-first approach became essential.

The company invested in double-blind, placebo-controlled studies, the type of research Arun described as the gold standard. It also supported studies across multiple regions, including North America, Korea, Turkey, Italy, and Germany, giving the ingredient a wider foundation than a single-market success story.

But science was only one part of the challenge.

Regulation added another layer.

When an ingredient has meaningful claims, those claims must be handled carefully. Stratum operates in a space where language matters, especially when brands are communicating benefits around joint comfort, exercise-induced pain, skin health, or mobility. Arun noted that Stratum’s regulatory team reviews messaging carefully and flags statements that could create problems, which means the company has to balance strong science with responsible communication.

That balance is not always easy.

Too much caution can make a breakthrough ingredient sound ordinary. Too much enthusiasm can create claims that do not survive review. For a B2B ingredient supplier, the responsibility is even greater because brand partners depend on Stratum not only for ingredients, but also for credible language they can safely bring to market.

There is also a practical constraint built into the ingredient itself.

Eggshell membrane is powerful because of its natural structure, but that structure has to be protected. The membrane must be processed from fresh shells in a way that prevents protein denaturation. That means Stratum’s relationship with the egg industry is not just part of the origin story. It remains part of the quality story.

The same waste stream that made the discovery possible also requires precision, timing, and consistency.

As Stratum expands beyond North America into Europe and Asia Pacific, these challenges become even more important. New markets bring new regulatory expectations, new consumer education needs, and new brand partners who may not yet understand why eggshell membrane deserves a place beside more established joint and collagen ingredients.

The Proof Behind a Collagen Ingredient People Can Actually Feel

For Stratum Nutrition, the real test of NEM was never whether the science sounded interesting.

It was whether people could feel a difference.

That matters in joint health because the category has trained consumers to wait. Many people who have tried traditional ingredients like glucosamine or chondroitin understand the familiar timeline. They take the product consistently, stay patient, and hope that somewhere around the three-month mark, their body begins to respond.

NEM created a different expectation.

Because it is effective at an ultra-low daily dose of about 500 mg for joint health and 400 mg for skin health, it does not follow the same formulation logic as many collagen products that require multiple grams per day. That alone makes it easier for brands to formulate with and easier for consumers to use consistently.

But the more compelling difference is speed.

Arun pointed to one claim that gives the ingredient its clearest market distinction.

“We even have a one-day pain claim approved by Health Canada for exercise-induced pain,” Arun explained.

That kind of claim changes the conversation because it gives brands something specific to build around and gives consumers a clearer reason to pay attention. In a category where people often expect delayed results, a one-day exercise-induced pain claim stands out because it suggests the ingredient is doing something more immediate inside the body.

The mechanism helps explain why.

NEM is processed in a way that partially hydrolyzes the eggshell membrane through an enzymatic process. In simple terms, that process releases peptides that are connected to the ingredient’s faster anti-inflammatory effect. At the same time, NEM retains native collagen components that appear to support longer-term benefits through oral tolerance, a process where the immune system learns to respond differently to specific collagen structures.

Arun described this dual action clearly.

“So it has got a bifunctional, or it attacks the issue in two different ways.”

That bifunctional approach is what makes NEM different from many ingredients that only work through one pathway. It gives the ingredient both an immediate and longer-term story, which matters for people looking to stay active, recover better, and maintain mobility as they age.

Stratum’s proof does not rest on mechanism alone.

The company has sold more than 1.75 billion doses, predominantly in North America, which gives the ingredient a level of real-world validation that few branded ingredients can claim. For a B2B ingredient supplier, that number matters because repeat use is one of the strongest signs that consumers are experiencing enough value to keep coming back.

The clinical foundation adds another layer.

NEM has been studied in double-blind, placebo-controlled trials, the kind of research Arun referred to as the gold standard. Its research footprint also extends beyond one region, with studies conducted across North America, Korea, Turkey, Italy, and Germany, including work with independent laboratories.

This gives Stratum something more durable than a trend.

It gives the company a body of evidence that supports how NEM is positioned in the market, both for joint health and for skin health. For supplement brands, that matters because consumers are becoming more specific in what they want. They are no longer looking only for general wellness products. They want ingredients tied to clear outcomes, credible studies, and practical use.

That is where NEM has found its place.

It gives brands a collagen ingredient that is low dose, fast-acting, and supported by research across multiple populations and regions.

And for consumers, it offers a different way to think about collagen.

Not as something that requires large scoops, long timelines, and vague expectations, but as an ingredient that can be formulated precisely for joint comfort, mobility, skin health, and healthy aging.

Ingredients Consumers Can Trust

Stratum Nutrition does not sell directly to the consumer.

Its role sits earlier in the chain, where supplement products are built before they ever reach a shelf, a practitioner’s recommendation, or a consumer’s daily routine. Stratum works with brand partners, the companies formulating dietary supplements and looking for ingredients that can give their products a stronger scientific foundation.

That distinction matters.

In a crowded wellness market, brands are under more pressure than ever to create products that are specific, credible, and easy for consumers to understand. General wellness claims no longer carry the same weight. People want to know what an ingredient does, how quickly it may work, how much is needed, and whether the science behind it can stand up to scrutiny.

This is where Stratum becomes valuable.

For brands building around mobility, NEM offers a clear use case. Joint and bone health matter across a wide age range because movement is often the foundation that determines everything else. As Arun explained in the interview, when mobility begins to decline, other health concerns tend to follow because daily activity becomes harder to sustain.

Stratum’s ingredients are most relevant for adults, ranging from younger active consumers in their twenties and thirties to older adults seeking better mobility and quality of life as they age. The company is not currently positioning NEM toward adolescents, largely because the research has not yet been built around that population.

The strongest consumer groups are adults dealing with exercise-induced discomfort, people with joint concerns, aging consumers focused on improving healthspan, and individuals who want more targeted support for skin, hair, nails, cognition, digestion, or inflammation pathways.

That is why Stratum’s portfolio now extends beyond eggshell membrane alone.

NEM remains the flagship ingredient for joint and mobility support, while Overlux brings eggshell membrane into the beauty category for skin, hair, and nails. Sage Extra supports cognition and women’s health. CurcuBrite addresses inflammatory pathways through an enhanced curcumin format. Ingredients like Bi-Muno, probiotics, and postbiotics allow Stratum to participate in digestive and microbiome-focused formulations.

The result is a portfolio designed for brands that want to build around specific outcomes, not broad wellness language.

Stratum also serves companies in the pet wellness space, where aging dogs and cats face many of the same mobility challenges humans do. As consumers become more attentive to their pets’ quality of life, ingredients that support joint comfort and movement are becoming increasingly relevant beyond the human supplement aisle.

For early-stage holistic health brands, established wellness companies, and supplement formulators targeting educated consumers, the appeal is practical.

Stratum gives them access to ingredients with a story, a mechanism, and research behind them. It also gives them a partner that understands the regulatory care required when communicating benefits in categories like joint pain, mobility, beauty, cognition, and healthy aging.

Consumers may not always know Stratum’s name when they pick up a finished product.

But if that product contains NEM, Overlux, or another Stratum ingredient, they are interacting with the company’s work.

That is the quiet influence of a B2B ingredient supplier.

It helps shape what brands can offer, what practitioners can recommend, and what consumers can trust when they are looking for products that do more than follow a trend.

Why Stratum Believes Healthspan Starts With Connective Tissue

For Stratum Nutrition, the message to the industry is becoming more focused as the market matures.

The future of joint, skin, and mobility support is not about selling more ingredients into crowded categories. It is about helping brands formulate products that can make a measurable difference in how people move, recover, age, and maintain quality of life.

That is where Stratum’s positioning around ultra-low-dose, efficacious collagen for healthspan becomes important.

NEM is not being presented as another collagen ingredient in a crowded field. It is being positioned around a more specific idea: connective tissue support as a foundation for whole-body health. When joints are stiff, movement declines. When movement declines, energy, independence, strength, mood, and long-term wellness can all be affected.

That is why mobility matters beyond pain relief.

It influences how people participate in their lives.

Arun emphasized that Stratum’s focus is not to build a massive catalog of generic ingredients. The company’s strategy is to go deeper on ingredients that are supported by science, differentiated in the market, and useful for brands trying to create condition-specific products.

That philosophy shows up most clearly in NEM.

At around 500 mg per day, NEM gives brands a lower-dose option compared with collagen ingredients that often require multiple grams. Its partially hydrolyzed structure also gives it a distinct position, especially when paired with clinical evidence and the Health Canada-approved claim for one-day relief of exercise-induced pain.

For brands, that matters because consumers are becoming more specific about what they expect from supplements.

They want products that are practical, easy to take, and tied to real outcomes.

They also want products that fit into a broader goal: living better for longer.

This is why Stratum’s healthspan narrative is so relevant. The company is not only talking about joints, skin, or collagen in isolation. It is connecting those categories through the common foundation of connective tissue, which affects how people move, how they recover, and how they age.

The same thinking is shaping what comes next.

In the near term, Stratum is focused on geographic expansion, with a stronger push into Europe and Asia Pacific, including an office in India to support regional growth. The company already has clinical research across multiple geographies, which gives it a stronger foundation as it enters markets where brands and consumers are increasingly demanding science-backed wellness ingredients.

Its portfolio is also continuing to broaden.

Alongside NEM and Overlux, Stratum is building around complementary ingredients in cognition, gut health, inflammatory pathways, and pet wellness. The pet category is especially meaningful because aging animals experience many of the same mobility challenges as humans, and younger consumers are increasingly investing in long-term wellness for their pets.

The larger strategy is clear.

Stratum wants to be the ingredient partner brands turn to when they want formulations that are differentiated, evidence-backed, and built around real consumer needs.

With more than 1.75 billion doses sold, its flagship ingredient already carries a proof point that many ingredient companies never reach. But the company’s next chapter appears to be less about defending what it has built and more about expanding where that science can go.

For the wellness industry, Stratum’s message is straightforward.

The next generation of supplements will not be defined by how many ingredients a brand can include.

It will be defined by whether those ingredients are specific, efficient, clinically supported, and capable of helping people maintain quality of life over time.

This Work Matters Beyond the Supplement Label

The story of Stratum Nutrition comes back to a simple idea: sometimes the most valuable health innovations begin with something everyone else has overlooked.

An eggshell membrane that once sat inside a waste problem became a clinically studied ingredient supporting mobility, skin health, and healthy aging. That shift matters because people are no longer looking for vague wellness promises. They want products that are specific, tested, practical, and able to fit into daily life.

For supplement brands, Stratum’s work is a reminder that better formulations begin long before a product reaches the consumer. They begin with sourcing, science, responsible claims, and a willingness to prove that an ingredient can do what the market says it should do.

For consumers and practitioners, it raises a different question.

What if the future of wellness is not louder, more complex, or more crowded, but simply more precise?

Stratum’s work matters because mobility, skin health, and healthy aging are not separate conversations. They are part of the same larger pursuit: helping people maintain quality of life for as long as possible.

To learn more about Stratum Nutrition and its ingredient portfolio for human health, visit stratumnutrition.com.

At MBNews, we spotlight the companies, practitioners, and innovators shaping the future of health from the inside out. If your work is helping people live better, move better, or age with more freedom, we invite you to join the conversation.